$PLTR

Moore Alexander D. sold $2.1M of PLTR

Moore Alexander D. sold 16,000 shares of Palantir Technologies Inc. (PLTR) at an average of $133.35 ($130.48–$134.44, $2.13M total) across 5 trades on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Moore Alexander D.
Published Jun 18, 2026, 12:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 12:04 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PLTR
Neutral
medium confidence
Mentioned
$PLTR
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLTRNeutralLow
01

Why it matters

The disclosed open-market sale (~$2.13M) is likely to be interpreted as routine planned selling; it may cause minor near-term sentiment noise but lacks new company fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this specific disclosure alone is unlikely to drive a durable repricing.

03

What to watch

The article doesn’t state whether other insiders sold/bought around the same time, nor does it quantify total insider net activity beyond this single director’s sale.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-17 for a 2026-06-15 sale; information becomes actionable on disclosure date.

Background

The filing is an SEC Form 4 insider transaction for Palantir director Moore Alexander D., executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$PLTRNeutralMedium confidence
Context

Palantir director Moore Alexander D. sold 16,000 shares in an open-market transaction on a 10b5-1 plan for ~$2.13M at ~$130.48–$134.44.

Expected impact

Low likelihood of sustained price impact; any reaction is likely short-lived unless paired with other news.

Evidence & confidence

The disclosure is a Form 4 insider sale under a pre-arranged 10b5-1 plan, with no accompanying operational/regulatory/financial change described.

Market effects

Minimal read-through to the software/AI sector; this is company-specific insider activity without new guidance or contract details.

No clear regional spillover; US-listed issuer with routine insider transaction disclosure.

Limited global relevance absent any international deal, regulation, or earnings/guidance change.

Counterpoint

Even 10b5-1 sales can coincide with periods of elevated valuation; traders may still use the timing as a sentiment check rather than a fundamental signal.

Key entities

  • Palantir Technologies Inc.

    US-listed company whose director executed a planned open-market sale disclosed via SEC Form 4.

  • Moore Alexander D.

    Director who sold 16,000 shares across five trades on 2026-06-15 under a 10b5-1 plan.

Related articles

$RTXMedAI 8/10

Pentagon warns arms makers to accelerate output as U.S. munitions crisis grows

The Pentagon, according to a memo reported by The Washington Post and confirmed by spokesman Sean Parnell, is urging defense contractors to accelerate production of critical munitions within 21 days, citing rapid U.S. missile and interceptor usage in the Iran war. CSIS estimates Patriot and THAAD stocks fell sharply. The memo also ties plans to shaping the fiscal 2028 defense budget.

$PLTRMed

PTIR Jumps 18% as Palantir Stock Rallies Yet Again

GraniteShares 2x Long PLTR Daily ETF (PTIR) rose about 18% after a weak jobs report boosted tech stocks and reduced expectations for a near-term Fed rate hike. The article links the move to Palantir’s Aug. 3 earnings, including Q2 revenue of $1.94B (+92.8% YoY) and raised FY revenue guidance to $8.15B-$8.158B.

$PLTRMedAI 8/10

Why Palantir, Zebra, and Gartner Soared

Palantir (PLTR) shares rose after quarterly results. It reported $1.94B revenue (+94% Y/Y) and forecast Q3 revenue up to $2.164B, above expectations. Gartner (IT) gained after Q2 results, with $1.7B revenue (+1.7% Y/Y) and free cash flow up 8.9% to $378M. Zebra (ZBRA) hit a 52-week high after Q2 EPS of $6.35 and raised full-year EPS range to $20.75-$21.25.